BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Diagnosis
23 results:

  • 1. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A preponderance of gastrointestinal cancer patients transition into cachexia syndrome.
    Gilmore LA; Olaechea S; Gilmore BW; Gannavarapu BS; Alvarez CM; Ahn C; Iyengar P; Infante RE
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2920-2931. PubMed ID: 36165100
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
    Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
    Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of various cancers in adults with abdominal aortic aneurysms.
    Cho HJ; Yoo JH; Kim MH; Ko KJ; Jun KW; Han KD; Hwang JK
    J Vasc Surg; 2023 Jan; 77(1):80-88.e2. PubMed ID: 35850163
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.
    Kobayashi-Taguchi K; Saitou T; Kamei Y; Murakami A; Nishiyama K; Aoki R; Kusakabe E; Noda H; Yamashita M; Kitazawa R; Imamura T; Takada Y
    Molecules; 2022 May; 27(10):. PubMed ID: 35630817
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]    [Full Text] [Related]  

  • 7. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National cancer Database.
    Amin S; Baine M; Meza J; Alam M; Lin C
    Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
    [No Abstract]    [Full Text] [Related]  

  • 10. Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients.
    Xiao J; Xu P; Li B; Hong T; Liu W; He X; Zheng C; Zhao Y
    Medicine (Baltimore); 2018 Feb; 97(8):e9767. PubMed ID: 29465558
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
    Suker M; Beumer BR; Sadot E; Marthey L; Faris JE; Mellon EA; El-Rayes BF; Wang-Gillam A; Lacy J; Hosein PJ; Moorcraft SY; Conroy T; Hohla F; Allen P; Taieb J; Hong TS; Shridhar R; Chau I; van Eijck CH; Koerkamp BG
    Lancet Oncol; 2016 Jun; 17(6):801-810. PubMed ID: 27160474
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
    Crippa S; Partelli S; Zamboni G; Scarpa A; Tamburrino D; Bassi C; Pederzoli P; Falconi M
    Surgery; 2014 Jan; 155(1):145-53. PubMed ID: 24646958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The effect of wait times on oncological outcomes from periampullary adenocarcinomas.
    McLean SR; Karsanji D; Wilson J; Dixon E; Sutherland FR; Pasieka J; Ball C; Bathe OF
    J Surg Oncol; 2013 Jun; 107(8):853-8. PubMed ID: 23625192
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting fasL.
    Wang P; Zhuang L; Zhang J; Fan J; Luo J; Chen H; Wang K; Liu L; Chen Z; Meng Z
    Mol Oncol; 2013 Jun; 7(3):334-45. PubMed ID: 23177026
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histological diagnosis by EUS-guided fine-needle aspiration biopsy in pancreatic solid masses without on-site cytopathologist: a single-center experience.
    Itoi T; Tsuchiya T; Itokawa F; Sofuni A; Kurihara T; Tsuji S; Ikeuchi N
    Dig Endosc; 2011 May; 23 Suppl 1():34-8. PubMed ID: 21535198
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.
    Röder C; Trauzold A; Kalthoff H
    Eur J Cell Biol; 2011; 90(6-7):450-5. PubMed ID: 21129814
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation.
    Eloubeidi MA; Tamhane A; Varadarajulu S; Wilcox CM
    Gastrointest Endosc; 2006 Apr; 63(4):622-9. PubMed ID: 16564863
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis.
    Nakai Y; Otsuka M; Hoshida Y; Tada M; Komatsu Y; Kawabe T; Omata M
    Oncol Rep; 2005 Nov; 14(5):1263-7. PubMed ID: 16211294
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Autoimmune pancreatitis presenting as a mass in the head of the pancreas: a diagnosis to differentiate from cancer.
    Tabata M; Kitayama J; Kanemoto H; Fukasawa T; Goto H; Taniwaka K
    Am Surg; 2003 May; 69(5):363-6. PubMed ID: 12769204
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.